Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous lidocaine to reduce propofol requirement during painless bronchoscopy
ChiCTR1900022178Phase 4Not yet recruiting
- Sponsor
- Hebei Provincial Hospital of Traditional Chinese Medicine
- Start
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of lidocaine (2 arms), sponsored by Hebei Provincial Hospital of Traditional Chinese Medicine. Primary endpoint: Propofol dosage. Planned start Apr 2019; status: not yet recruiting.
02
Drugs
lidocaine
Beyond the preview
Go deeper on ChiCTR1900022178.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900022178.